...
机译:颈部鳞状细胞癌侵袭和转移预后评价的扭转1,蜗牛和鳞状细胞癌抗原的组合检测
Harbin Med Univ Dept Obstet &
Gynecol Affiliated Hosp 2 Harbin 150086 Heilongjiang Peoples R;
Harbin Med Univ Dept Obstet &
Gynecol Affiliated Hosp 2 Harbin 150086 Heilongjiang Peoples R;
Harbin Med Univ Dept Obstet &
Gynecol Affiliated Hosp 2 Harbin 150086 Heilongjiang Peoples R;
Jiamusi Univ Dept Obstet &
Gynecol Hosp 1 Jiamusi Peoples R China;
Harbin Med Univ Dept Obstet &
Gynecol Affiliated Hosp 2 Harbin 150086 Heilongjiang Peoples R;
Harbin Med Univ Dept Obstet &
Gynecol Affiliated Hosp 2 Harbin 150086 Heilongjiang Peoples R;
Harbin Med Univ Dept Obstet &
Gynecol Affiliated Hosp 2 Harbin 150086 Heilongjiang Peoples R;
Harbin Med Univ Dept Obstet &
Gynecol Affiliated Hosp 2 Harbin 150086 Heilongjiang Peoples R;
Harbin Med Univ Dept Obstet &
Gynecol Affiliated Hosp 2 Harbin 150086 Heilongjiang Peoples R;
Twist1; Snail1; Squamous cell carcinoma antigen; Cervical squamous cell carcinoma;
机译:颈部鳞状细胞癌侵袭和转移预后评价的扭转1,蜗牛和鳞状细胞癌抗原的组合检测
机译:血清LNCRNA(CCAT2,LINC01133,LINC00511)与鳞状细胞癌抗原板作为新型非侵入性生物标志物,用于检测宫颈鳞状癌
机译:血清鳞状细胞癌抗原水平预测宫颈鳞状细胞癌患者化学敏感性,淋巴结转移和预后的临床价值
机译:淋巴结转移模式在食管鳞状细胞癌患者中的预后影响
机译:头颈部鳞状细胞癌化学耐药性,侵袭和转移的表观遗传学调控。
机译:血清LNCRNA(CCAT2LINC01133LINC00511)与鳞状细胞癌抗原板作为新型非侵入性生物标志物用于检测宫颈鳞状癌
机译:鳞状细胞癌抗原在子宫子宫颈鳞状细胞癌侵袭和转移中的参与